Pfizer noted it has completed its acquisition of all outstanding shares of the company’s common stock for $65.60 per share in ...

Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of ...

President Trump's new pharmaceutical tariff policy throws another wrench into an already increasingly complex drug supply ...

ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...

In today’s Pharmaceutical Executive Daily, WeightWatchers plans to offer Novo Nordisk’s oral Wegovy pending FDA approval, FDA ...

With sluggish pharmaceutical sales in the third quarter coming in below analysts’ expectations, Bayer is acutely aware of the challenges facing its key unit. | Despite the largely stagnant performance ...

Par Health, Inc. ("Par Health" or the "Company") today announced that it has successfully completed its previously announced spin-off from ...

President Donald Trump’s Oval Office press conference on Thursday, November 6, came to an abrupt halt as Novo Nordisk ...

A strategic and financial recalibration on psychiatric drug development brings profound implications for investors, insurers, ...

Teva Pharmaceutical Industries (NYSE: TEVA) had a day on the stock market to remember on Wednesday. The drugmaker 's share ...

Pharmaceutical antitrust presents unique challenges to antitrust law. Market forces are different for pharmaceuticals than they are for most other products: The party who chooses the product is ...

A comprehensive Hungarian study has revealed that the behavior of pharmaceutical residues in soil does not depend on a single factor, but is shaped by several interacting processes. The researchers ...